Psilocybin Articles Archives

Oregon Dropped Its Psilocybin Fee Hike After Licensees Said They Would Walk

The Oregon Health Authority wanted $20,000 annual licenses. Community surveys suggested enough licensees would quit that the state would collect less than it does today.

The DEA Wants Five More Tryptamines in Schedule I. Comments Close October 23

A proposed rule would place five tryptamines into Schedule I. It is the second attempt at the same action, and comments close October 23.

An MDMA Course Takes 34 Clinician Hours Per Patient

Israeli MDMA trials run 15 sessions over three to four months, including an eight hour dosing day with two therapists present. The staffing math is the part US clinics should be reading.

6 Regulatory Deadlines Ketamine Clinics Should Have on the Calendar

From FDA's October 5 psychedelics docket to the DEA telehealth expiration and Medicare's 2027 in-person rule, six dates every ketamine clinic should plan around.

The First Psilocybin Clinics Will Probably Be Spravato Clinics

Virginia passed a trigger law for FDA-approved psilocybin, and both Compass Pathways and Journey Clinical plan to launch at existing Spravato sites.

FDA’s Psychedelics Hearing Was Really a Fight Over the Label

FDA heard four hours of testimony on psychedelic approval and asked no questions. The real contest was over label language, which decides who can deliver these drugs.

Medicaid Is the Largest Behavioral Health Payer. A New Report Asks What Happens Next

A Center for Health Care Strategies report examines how psychedelic-assisted therapy could reach Medicaid. Some states already cover off-label IV ketamine.

The Only Two Placebo-Controlled Microdosing Trials Found Nothing

A systematic review screened 897 references on psilocybin microdosing. Of 11 studies, only two were placebo controlled, and neither found a benefit.

Psilocybin Protected Nerves From Chemo in Mice. A Non-Hallucinogenic Version Worked Too

A Science paper found psilocybin prevented chemotherapy nerve damage in mice across six treatment cycles. A non-hallucinogenic compound did the same.

The American Legion Just Backed a Specific Psychedelics Bill, Not Just the Idea

The American Legion adopted a resolution backing psychedelic therapy for veterans. It endorses S.4220, which would build a VA office and ban step therapy.